Dose-response Effects of Aerobic Exercise Among Colon Cancer Survivors: A Randomized Phase II Trial

Clinical Colorectal Cancer

Volumn 17, Issue 1, 2018, Pages 32-40

  Brown, Justin C ^a   Troxel, Andrea B ^b   Ky, Bonnie ^c   Damjanov, Nevena ^c   Zemel, Babette S ^d   Rickels, Michael R ^c   Rhim, Andrew D ^e   Rustgi, Anil K ^c   Courneya, Kerry S ^f   Schmitz, Kathryn H ^g  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF ALBERTA   (Canada)

^g PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Biomarkers; Energy balance; Lifestyle; Physical activity; Survivorship

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; VASCULAR ADHESION PROTEIN 1; AMINE OXIDASE (COPPER CONTAINING); AOC3 PROTEIN, HUMAN; CELL ADHESION MOLECULE; ICAM1 PROTEIN, HUMAN; TUMOR MARKER;

ABDOMINAL PAIN; ADULT; AEROBIC EXERCISE; ALOPECIA; ARTHRALGIA; ARTHRITIS; ARTICLE; BACKACHE; BLISTER; BLURRED VISION; CANCER SURVIVOR; CEREBROVASCULAR ACCIDENT; CHILL; CLINICAL ARTICLE; COLON CANCER; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASES; DIZZINESS; DRY EYE; EXTERNAL EAR DISEASE; FALLING; FATIGUE; FEMALE; FLU LIKE SYNDROME; FOOT DISEASE; GASTROESOPHAGEAL REFLUX; HEADACHE; HOT FLUSH; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTHYROIDISM; INSOMNIA; LIMB PAIN; LIP DISEASE; LOWER LIMB; LYMPH NODE PAIN; MALE; MASTALGIA; MIDDLE AGED; MOUTH PAIN; MUSCLE WEAKNESS; MYALGIA; NECK PAIN; NEURALGIA; NONCARDIAC CHEST PAIN; OTITIS; OTITIS MEDIA; PERIPHERAL EDEMA; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SINUS PAIN; SKIN BRUISING; SNEEZING; TOOTH PAIN; UPPER RESPIRATORY TRACT INFECTION; VOMITING; XEROSTOMIA; AGED; BLOOD; CLINICAL TRIAL; COLON TUMOR; EXERCISE; KINESIOTHERAPY; PHASE 2 CLINICAL TRIAL; PREVENTION AND CONTROL; PROCEDURES; TUMOR RECURRENCE;

ADULT; AGED; AMINE OXIDASE (COPPER-CONTAINING); BIOMARKERS, TUMOR; CANCER SURVIVORS; CELL ADHESION MOLECULES; COLONIC NEOPLASMS; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 85021314484     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2017.06.001     Document Type: Article

References (31)

1. Ferlay, J., Soerjomataram, I., Dikshit, R., et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
2. Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350 (2004), 2050–2059.
3. André, T., Boni, C., Mounedji-Boudiaf, L., et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350 (2004), 2343–2351.
4. Quasar Collaborative Group. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370 (2007), 2020–2029.
5. Meyerhardt, J.A., Heseltine, D., Niedzwiecki, D., et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 24 (2006), 3535–3541.
6. Meyerhardt, J.A., Giovannucci, E.L., Ogino, S., et al. Physical activity and male colorectal cancer survival. Arch Intern Med 169 (2009), 2102–2108.
7. Meyerhardt, J.A., Giovannucci, E.L., Holmes, M.D., et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24 (2006), 3527–3534.
8. Schmid, D., Leitzmann, M.F., Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol 25 (2014), 1293–1311.
9. Rock, C.L., Doyle, C., Demark-Wahnefried, W., et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62 (2012), 243–274.
10. Schmitz, K.H., Courneya, K.S., Matthews, C., et al. American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42 (2010), 1409–1426.
11. Denlinger, C.S., Ligibel, J.A., Are, M., et al. Survivorship: healthy lifestyles, version 2.2014. J Natl Compr Canc Netw 12 (2014), 1222–1237.
12. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. 8th ed., 2013, Lippincott Williams & Wilkins, Philadelphia.
13. Winters-Stone, K.M., Neil, S.E., Campbell, K.L., Attention to principles of exercise training: a review of exercise studies for survivors of cancers other than breast. Br J Sports Med 48 (2013), 987–995.
14. Cramer, H., Lauche, R., Klose, P., Dobos, G., Langhorst, J., A systematic review and meta-analysis of exercise interventions for colorectal cancer patients. Eur J Cancer Care 23 (2014), 3–14.
15. Brown, J.C., Schmitz, K.H., The prescription or proscription of exercise in colorectal cancer care. Med Sci Sports Exerc 46 (2014), 2202–2209.
16. Paschos, K.A., Canovas, D., Bird, N.C., The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell Signal 21 (2009), 665–674.
17. Alexiou, D., Karayiannakis, A.J., Syrigos, K.N., et al. Serum levels of E-selectin, ICAM-1, and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer 37 (2001), 2392–2397.
18. Okugawa, Y., Miki, C., Toiyama, Y., Koike, Y., Inoue, Y., Kusunoki, M., Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma. Dis Colon Rectum 52 (2009), 1330–1336.
19. Toiyama, Y., Miki, C., Inoue, Y., et al. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients. Ann Surg Oncol 15 (2008), 1617–1624.
20. Yamada, Y., Arao, T., Matsumoto, K., et al. Plasma concentrations of VCAM-1 and PAI-1: a predictive biomarker for post-operative recurrence in colorectal cancer. Cancer Sci 101 (2010), 1886–1890.
21. Toiyama, Y., Miki, C., Inoue, Y., Kawamoto, A., Kusunoki, M., Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis. J Surg Oncol 99 (2009), 368–372.
22. Schlesinger, M., Bendas, G., Vascular cell adhesion molecule-1 (VCAM-1)—an increasing insight into its role in tumorigenicity and metastasis. Int J Cancer 136 (2015), 2504–2514.
23. Howard, K., Lo, K.K., Ao, L., et al. Intercellular adhesion molecule-1 mediates murine colon adenocarcinoma invasion. J Surg Res 187 (2014), 19–23.
24. Brown, J.C., Troxel, A.B., Ky, B., et al. A randomized phase II dose-response exercise trial among colon cancer survivors: purpose, study design, methods, and recruitment results. Contemp Clin Trials 47 (2016), 366–375.
25. Paffenbarger, R., Wing, A., Hyde, R., Paffenbarger physical activity questionnaire. Am J Epidemiol 108 (1978), 161–175.
26. Pleis, J.R., Lucas, J.W., Ward, B.W., Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Vital Health Stat 10, 2009, 1–157.
27. Troiano, R.P., Berrigan, D., Dodd, K.W., Masse, L.C., Tilert, T., McDowell, M., Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 40 (2008), 181–188.
28. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002), 111–117.
29. Weiser, M.R., Gonen, M., Chou, J.F., Kattan, M.W., Schrag, D., Predicting survival after curative colectomy for cancer: Individualizing colon cancer staging. J Clin Oncol 29 (2011), 4796–4802.
30. US Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE) version 4.0. National Institutes of Health, National Cancer Institute(03), 2009, 4.
31. Fitzmaurice, G., Laird, N., Ware, J., Applied longitudinal analysis. 2004, Wiley, Hoboken, New Jersey.